Compile Data Set for Download or QSAR
maximum 50k data
Found 24 Enz. Inhib. hit(s) with all data for entry = 50011586
TargetUrokinase-type plasminogen activator(Homo sapiens (Human))
Pfizer

Curated by ChEMBL
LigandPNGBDBM50108364(CHEMBL293098 | N-(5-Bromo-3-chloro-pyridin-2-yl)-g...)
Affinity DataKi:  2.90E+3nMAssay Description:In vitro inhibition of HWMT human urokinase Plasminogen activator.More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetUrokinase-type plasminogen activator(Homo sapiens (Human))
Pfizer

Curated by ChEMBL
LigandPNGBDBM50108362(CHEMBL54357 | N-(5-Bromo-pyridin-2-yl)-guanidine)
Affinity DataKi:  3.13E+3nMAssay Description:In vitro inhibition of HWMT human urokinase Plasminogen activator.More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetUrokinase-type plasminogen activator(Homo sapiens (Human))
Pfizer

Curated by ChEMBL
LigandPNGBDBM50108360(CHEMBL55125 | N-(3-Bromo-5-chloro-pyridin-2-yl)-gu...)
Affinity DataKi:  4.83E+3nMAssay Description:In vitro inhibition of HWMT human urokinase Plasminogen activator.More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetUrokinase-type plasminogen activator(Homo sapiens (Human))
Pfizer

Curated by ChEMBL
LigandPNGBDBM50108354(CHEMBL292900 | N-(3,5-Dichloro-pyridin-2-yl)-guani...)
Affinity DataKi:  5.47E+3nMAssay Description:In vitro inhibition of HWMT human urokinase Plasminogen activator.More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetUrokinase-type plasminogen activator(Homo sapiens (Human))
Pfizer

Curated by ChEMBL
LigandPNGBDBM50053590(1N-amino(immino)methyl-4-chloroaniline | CHEMBL410...)
Affinity DataKi:  6.70E+3nMAssay Description:In vitro inhibition of HWMT human urokinase Plasminogen activator.More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetUrokinase-type plasminogen activator(Homo sapiens (Human))
Pfizer

Curated by ChEMBL
LigandPNGBDBM50108355(CHEMBL54467 | N-(4-Phenyl-pyridin-2-yl)-guanidine)
Affinity DataKi:  7.10E+3nMAssay Description:In vitro inhibition of HWMT human urokinase Plasminogen activator.More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetUrokinase-type plasminogen activator(Homo sapiens (Human))
Pfizer

Curated by ChEMBL
LigandPNGBDBM50108352(CHEMBL55808 | N-(3,5-Dichloro-4-methyl-pyridin-2-y...)
Affinity DataKi:  8.70E+3nMAssay Description:In vitro inhibition of HWMT human urokinase Plasminogen activator.More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetUrokinase-type plasminogen activator(Homo sapiens (Human))
Pfizer

Curated by ChEMBL
LigandPNGBDBM50108363(CHEMBL298989 | N-(5-Chloro-pyridin-2-yl)-guanidine)
Affinity DataKi:  1.00E+4nMAssay Description:In vitro inhibition of HWMT human urokinase Plasminogen activator.More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetPlasminogen(Homo sapiens (Human))
Pfizer

Curated by ChEMBL
LigandPNGBDBM50108353(CHEMBL298550 | N-Pyridin-4-yl-guanidine)
Affinity DataKi:  1.69E+4nMAssay Description:Ability to inhibit human plasmin using Chromozym-PL as substrateMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetUrokinase-type plasminogen activator(Homo sapiens (Human))
Pfizer

Curated by ChEMBL
LigandPNGBDBM50053618(CHEMBL128047 | N-Pyridin-2-yl-guanidine)
Affinity DataKi:  2.95E+4nMAssay Description:In vitro inhibition of HWMT human urokinase Plasminogen activator.More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetUrokinase-type plasminogen activator(Homo sapiens (Human))
Pfizer

Curated by ChEMBL
LigandPNGBDBM50108365(CHEMBL53031 | N-(5-Methyl-pyridin-2-yl)-guanidine)
Affinity DataKi:  3.23E+4nMAssay Description:In vitro inhibition of HWMT human urokinase Plasminogen activator.More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetUrokinase-type plasminogen activator(Homo sapiens (Human))
Pfizer

Curated by ChEMBL
LigandPNGBDBM50108358(CHEMBL52361 | N-(3-Methyl-pyridin-2-yl)-guanidine)
Affinity DataKi:  3.77E+4nMAssay Description:In vitro inhibition of HWMT human urokinase Plasminogen activator.More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetUrokinase-type plasminogen activator(Homo sapiens (Human))
Pfizer

Curated by ChEMBL
LigandPNGBDBM50108361(CHEMBL53032 | N-(3-Chloro-5-trifluoromethyl-pyridi...)
Affinity DataKi:  4.07E+4nMAssay Description:In vitro inhibition of HWMT human urokinase Plasminogen activator.More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetPlasminogen(Homo sapiens (Human))
Pfizer

Curated by ChEMBL
LigandPNGBDBM50053590(1N-amino(immino)methyl-4-chloroaniline | CHEMBL410...)
Affinity DataKi: <5.00E+4nMAssay Description:Ability to inhibit human plasmin using Chromozym-PL as substrateMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetUrokinase-type plasminogen activator(Homo sapiens (Human))
Pfizer

Curated by ChEMBL
LigandPNGBDBM50108367(CHEMBL55184 | N-(4-Methoxy-pyridin-2-yl)-guanidine)
Affinity DataKi:  5.33E+4nMAssay Description:In vitro inhibition of HWMT human urokinase Plasminogen activator.More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetUrokinase-type plasminogen activator(Homo sapiens (Human))
Pfizer

Curated by ChEMBL
LigandPNGBDBM50108359(CHEMBL300135 | N-(3-Methoxy-pyridin-2-yl)-guanidin...)
Affinity DataKi:  6.20E+4nMAssay Description:In vitro inhibition of HWMT human urokinase Plasminogen activator.More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetUrokinase-type plasminogen activator(Homo sapiens (Human))
Pfizer

Curated by ChEMBL
LigandPNGBDBM50108366(CHEMBL54640 | N-(4-Methyl-pyridin-2-yl)-guanidine)
Affinity DataKi:  8.38E+4nMAssay Description:In vitro inhibition of HWMT human urokinase Plasminogen activator.More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetUrokinase-type plasminogen activator(Homo sapiens (Human))
Pfizer

Curated by ChEMBL
LigandPNGBDBM50108356(CHEMBL55051 | N-(3-Hydroxy-pyridin-2-yl)-guanidine)
Affinity DataKi:  1.47E+5nMAssay Description:In vitro inhibition of HWMT human urokinase Plasminogen activator.More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetUrokinase-type plasminogen activator(Homo sapiens (Human))
Pfizer

Curated by ChEMBL
LigandPNGBDBM50108357(CHEMBL54545 | N-(6-Methyl-pyridin-2-yl)-guanidine)
Affinity DataKi:  1.73E+5nMAssay Description:In vitro inhibition of HWMT human urokinase Plasminogen activator.More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetPlasminogen(Homo sapiens (Human))
Pfizer

Curated by ChEMBL
LigandPNGBDBM50108352(CHEMBL55808 | N-(3,5-Dichloro-4-methyl-pyridin-2-y...)
Affinity DataKi:  1.77E+5nMAssay Description:Ability to inhibit human plasmin using Chromozym-PL as substrateMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetPlasminogen(Homo sapiens (Human))
Pfizer

Curated by ChEMBL
LigandPNGBDBM50108359(CHEMBL300135 | N-(3-Methoxy-pyridin-2-yl)-guanidin...)
Affinity DataKi: <2.33E+5nMAssay Description:Ability to inhibit human plasmin using Chromozym-PL as substrateMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetPlasminogen(Homo sapiens (Human))
Pfizer

Curated by ChEMBL
LigandPNGBDBM50108365(CHEMBL53031 | N-(5-Methyl-pyridin-2-yl)-guanidine)
Affinity DataKi:  2.45E+5nMAssay Description:Ability to inhibit human tissue plasminogen activator stimulatorMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetTissue-type plasminogen activator(Homo sapiens (Human))
Pfizer

Curated by ChEMBL
LigandPNGBDBM50108360(CHEMBL55125 | N-(3-Bromo-5-chloro-pyridin-2-yl)-gu...)
Affinity DataKi:  2.72E+5nMAssay Description:Ability to inhibit human tissue plasminogen activator stimulatorMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetUrokinase-type plasminogen activator(Homo sapiens (Human))
Pfizer

Curated by ChEMBL
LigandPNGBDBM50108368(CHEMBL54989 | N-Pyrimidin-2-yl-guanidine)
Affinity DataKi:  2.92E+5nMAssay Description:In vitro inhibition of HWMT human urokinase Plasminogen activator.More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed